Diabetes Flashcards

1
Q

Blood glucose should always be above what while driving?

A

5mmoll

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What action should be taken if BG falls below 4 while driving?

A

Stop the vehicle, eat/drink sugar and wait until 45 minutes after blood glucose has returned to normal before continuing therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HBA1c test reflects the average plasma glucose levels over how long?

A

Over the previous 2 to 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Do patients need to fast for a HbA1c test?

A

No - unlike the oral glucose tolerance test, an HbA1c test can be performed at any time of the day and does not require any special preparation such as fasting.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When should HBA1c NOT be used to diagnose diabetes?

A

suscepted Type ONE diabetes, in children, during pregnancy or in women who are up to two months post partum. Should also not be used if patient has had symptoms of diabetes for less than two months, inpatients taking medication that can cause hyperglycemia, end stage CKD and HIV infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

A target HbA1C of what is recommended in patients with type 1 diabetes?

A

48

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How often should BG concentrations be measured in T1DM?

A

At least four times a day, including before each meal and before bed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Patients with T1DM should aim for what BG concentration on waking?

A

5-7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Patients with T1DM should aim for what BG concentration before meals?

A

4-7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Patients with T1DM should aim for what BG concentration 90 minutes after eating?

A

5-9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the first line recommended insulin regimen in T1DM?

A

Multiple daily injection basal-bolus regimen.

Insulin determir BD (or once daily insulin glargline) and a rapid acting insulin with meals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

If a basal bolus regimen is not appropriate in T1DM what is the next regimen that should be offered?

A

A twice daily mixed insulin regimen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When can a continuous subcut insulin infusion be considered in diabetes?

A

Should only be offered to adults who suffer with disabling hypos, or who have a high HbA1c conc >69

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How would infection, stress or trauma impact on insulin requirements?

A

May increase the required insulin dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How might physical activity, intercurrent illness and reduce food intake impact on insulin requirements?

A

May decrease the insulin requirements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name the three rapid acting insulins

A

Gluisine, aspart and lispro (GAL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why might a DPP-4 inhibitor be beneficial?

A

Do not appear to be associated with weight gain and have less incidence of hypoglycemia that with SU

18
Q

Why is the role of repaglinide in T2DM limited?

A

Only licensed in combination with metformin

19
Q

Why should ACEi be used with caution in patients with diabetes?

A

ACEi can potentiate the hypoglycemia effect of insulin and oral antidiabetic drugs

20
Q

How should insulin be managed before/during and after major surgery?

A

On the day before surgery - once daily long acting insulin should be given at 80% of the usual dose. Other insulin should be given as normal.

On the day of surgery - continue at 80% of the normal dose, all other insulin should be stopped until patient is eating and drinking again.

During surgery start an VRIII

Conversion back to s/c insulin should not beginuntil the patient can eat and drink without nausea or vomiting. The VRIII and IV fluids should be continued for 30-60 minutes after the first meal time short acting insulin dose.

21
Q

Can GLP-1 agonists be continued during surgery?

A

Yes can be taken as normal during the whole peri-op period

22
Q

How should SGLT2 inhibitors be managed before surgery?

A

Should be omitted on the day of surgery and not restarted until the patient is stable. Their use during periods of dehydration andacute illness is associated with an increased risk of ketoacidosis.

23
Q

How should SU be managed in patients undergoing surgery?

A

SU are associated with hypglycemia in the fasted state and therefore should always be omitted on the day of surgery and until the patient eating and drinking again.

24
Q

How should metformin be managed in patients undergoing surgery?

A

Metformin is renally excreted, renal impairment may lead to accumulation and lactic acidosis during surgery. If only one meal with be missed during surgery and the patients eGFR is greater than 60 and alow risk of AKI (and the procedure does not involve administration of contrast media), it may be possible to continue metformin - lunch time dose should be omitted.

If the patient will miss more than one meal or if there is a signif risk of the patient developing an AKI it should be stopped when fasting begins and a VRIII should be started if the dose is more than once daily.

Restart once eating and drinking again and renal function has been assured.

25
Q

Which oral antidiabetic drugs must be stopped during illness?

A

SGLT-2 inhibitors

26
Q

Signs of lactic acidosis include?

A

Dysponea, muscle cramps, abdominal pain, hypothermia, or asthenia.

27
Q

Metformin monitoring requirements

A

Renal function should be determined before treatment and at lest annually.

28
Q

DPP4 inhibitors can lead to what serious side effect?

A

Pancreatitis - discontinue if symptoms of acute pancreatitis occur (persistent, severe abdominal pain)

29
Q

Important side effects with exenatide (and other GLP-1 agonists)

A

Severe pancreatitis (sometimes fatal) including haemorrhagic or necrotising pancreatitis has been reported rarely. Discontinue permanently if diagnosed.

30
Q

Exenatide patient advice

A

Some oral medications hsould be taken at least 1 hour before or 4 hours after injection.
Inform patient on signs of pancreatitis.

31
Q

Exenatide missed dose advice

A

If a dose is missed continue with the next scheduled dose - do not administere after meal.

32
Q

How often is liraglutide (saxenda/victoza) administered?

A

Once a week

33
Q

How should liraglutaide be stored?

A

Store in a refrigerator, after first use can be stored below 30’C, discard 1 month after first use

34
Q

SGLT-2 important safety information

A

Risk of DKA

35
Q

Canagliflozin important safety information

A

Increased risk of lower limb amputation (does not apply to the other flozins). Consider stoping if a patient develops a significant lower limb complication e.g. ulcer, osteomyelitis.
and
DKA

36
Q

SGLT-2 monitoring requirements

A

Determine renal function before treatment and at least annually thereafter and before initiation of concomitant drugs that reduce renal function and periodically thereafter.

37
Q

SLGT-1 patient and carer advice

A

Patients should be advised to report symptoms of volume depletion, including postural hypotension and dizziness. Patients should be informed of the signs and symptoms of DKA.

38
Q

Pioglitazone important safety information

A

Increased risk of heart failure - incidence of HF is increased when pioglitazone is combined with insulin, especially in patients with predisposing factors e.g. MI. Should not be used in patients with HF.

Risk of bladder cancer. Patients should be advise to report anyhaematuria, dysuria or urinary urgency.

39
Q

Pioglitazone contraindications

A

History of HF, previous or active bladder cancer, uninvestigated blood in urine.

Also caution in those at increased risk of bone fractures, particularly women.

40
Q

Insulins important safety information (MHRA alert)

A

Risk of severe harm and death due to withdrawing insulin from pen devices.